Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus (SLE)

被引：0
|
作者：
Yip, Jonathan [1 ]
Aghdassi, Ellie [1 ]
Su, Jiandong [2 ]
Lou, Wendy [3 ]
Reich, Heather [1 ]
Bargman, Joanne [1 ]
Scholey, James [1 ]
Gladman, Dafna [3 ]
Urowitz, Murray [3 ]
Fortin, Paul R. [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2010年 / 37卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
158
引用
收藏
页码：1326 / 1326
页数：1
相关论文
共 50 条
  • [1] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus
    Yip, Jonathan
    Aghdassi, Elaheh
    Su, Jiandong
    Lou, Wendy
    Reich, Heather
    Bargman, Joanne
    Scholey, James
    Gladman, Dafna D.
    Urowitz, Murray B.
    Fortin, Paul R.
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1667 - 1672
  • [2] DNA IN SERUM OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    TAN, EM
    SCHUR, PH
    KUNKEL, HG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1965, 44 (06): : 1104 - &
  • [3] Clinical disease activity and nephritis associated serum antibody profiles in patients with systemic lupus erythematosus (SLE).
    Ravirajan, CT
    Rowse, L
    Isenberg, DA
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S113 - S113
  • [4] CYTOTOXICITY OF SERUM IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - EFFECTS OF TREATMENT AND DISEASE ACTIVITY
    LAVASTIDA, MT
    GOLDSTEIN, AL
    DANIELS, JC
    [J]. CLINICAL RESEARCH, 1978, 26 (03): : A380 - A380
  • [5] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Mader, Reuven
    Mishail, Samer
    Adawi, Muhammed
    Lavi, Idit
    Luboshitzky, Rafael
    [J]. CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1891 - 1894
  • [6] Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity
    Reuven Mader
    Samer Mishail
    Muhammed Adawi
    Idit Lavi
    Rafael Luboshitzky
    [J]. Clinical Rheumatology, 2007, 26 : 1891 - 1894
  • [7] Serum thrombomodulin - a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity
    Boehme, MWJ
    Raeth, U
    Galle, PR
    Stremmel, W
    Scherbaum, WA
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01): : 189 - 195
  • [8] ASSESSMENT OF DISEASE ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    WINFIELD, JB
    BRUNNER, CM
    DAVIS, JS
    OBRIEN, WM
    [J]. ARTHRITIS AND RHEUMATISM, 1972, 15 (04): : 462 - &
  • [9] The effect of race on disease activity in systemic lupus erythematosus (SLE).
    Ghaussy, NO
    Sibbitt, WL
    Bankhurst, AD
    Qualls, CR
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S143 - S143
  • [10] DISEASE ACTIVITY INDICES (DAIS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Wyrwich, K.
    Winnette, R.
    Oglesby, A.
    Narayanan, S.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A508 - A508
12345